Charles Schwab
OMIC

Charles Schwab’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Charles Schwab’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-783
Closed -$19.5K – 3650
2023
Q2 		$19.5K Sell
783
-4,229
-84% -$124K ﹤0.01% 3562
2023
Q1 		$182K Hold
5,012
– – ﹤0.01% 3169
2022
Q4 		$302K Buy
5,012
+194
+4% +$13K ﹤0.01% 3111
2022
Q3 		$362K Buy
4,818
+735
+18% +$76.8K ﹤0.01% 3082
2022
Q2 		$468K Buy
4,083
+423
+12% +$49.6K ﹤0.01% 3103
2022
Q1 		$693K Buy
3,660
+2,614
+250% +$605K ﹤0.01% 2992
2021
Q4 		$363K Buy
1,046
+70
+7% +$27.1K ﹤0.01% 3247
2021
Q3 		$328K Buy
+976
New +$500K ﹤0.01% 3247

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab's OMIC Position: Q3 2023 in Review

Charles Schwab sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2023, closing a stake of 783 shares — an estimated $19.5K sold.

Charles Schwab first reported a position in OMIC in Q3 2021 and held it in 8 quarters. The position peaked at $693K in Q1 2022. 48 funds tracked by Wall St. Rank hold OMIC as of Q3 2023.

  • Charles Schwab reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Charles Schwab sold 783 Singular Genomics Systems, Inc. Common Stock shares in Q3 2023, an estimated $19.5K.
  • Charles Schwab first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Charles Schwab's Singular Genomics Systems, Inc. Common Stock position peaked at $693K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.